MIRM

NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$94.51

-11.28 (-10.66%)

As of Aug 6, 9:52 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -29.4% upside

Low Target $36.90

Average Target $66.73

High Target $76.87

Current Price $94.51

Current
$94.51

Target
$66.73

$36.90 $66.73 avg $76.87

Scenario Analysis

Bear Case

$36.90

-61.0%

Low target

Base Case

$66.73

-29.4%

Avg target

Bull Case

$76.87

+-18.7%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$130.00

-27.3% from high

52-Week Low

$50.25

+88.1% from low

50-Day SMA

$87.61

+7.9% vs SMA

200-Day SMA

$68.12

+38.7% vs SMA

RSI (14)

56.6

Neutral

Target vs 52W High

$66.73

-48.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.0%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+171.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-43.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.3%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%